GlassScriptPhysician profile
Emmanuel Aguh
NPI 1588058549
$3,420.33
in general payments reported to CMS, 2019-2025
17 companies · $2,500 in 2025
The $2,500 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $168 · 2021: $98.35 · 2022: $115 · 2023: $346 · 2025: $2,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $345.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,500.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $224.55 | 2020-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $149.57 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $141.46 | 2022-2023 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $81.29 | 2019-2022 | |
| Csl Behring | $57.79 | 2023 | Kcentra |
| Astrazeneca Pharmaceuticals LP | $49.84 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $39.01 | 2023 | Ultomiris |
| Janssen Scientific Affairs, LLC | $31.43 | 2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.32 | 2019 | |
| Vifor Pharma, INC. | $19.60 | 2019 | |
| Melinta Therapeutics, LLC | $19.03 | 2019 | |
| Medtronic, INC. | $18.96 | 2023 | Linq II |
| Pfizer INC. | $18.55 | 2023 | |
| Gilead Sciences, INC. | $18.36 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.25 | 2019 | |
| Mylan Specialty L.P. | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuel Aguh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.